Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma
- 16 September 2011
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 26 (4) , 844-845
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Associations between multiple myeloma and other malignanciesLeukemia & Lymphoma, 2011
- Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndromeBMC Medical Genetics, 2010
- Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myelomaLeukemia & Lymphoma, 2010
- Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989Blood, 2008
- Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group studyEuropean Journal of Haematology, 2000
- Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myelomaBritish Journal of Haematology, 1996
- A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosisBritish Journal of Cancer, 1987
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Multiple Myeloma and Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1970